“…The biological activity of the compounds is mainly dependent on their molecular structures (Salimon et al ., 2010 ). A vast number of 1,3,4-thiadiazoles have been reported as potential pharmacologically active compounds with antimicrobial (Patil and Biradar, 2001 ; Zamani et al ., 2004 ; Sharma et al ., 2006 ), antiviral (Pandey et al ., 2004 ), antitubercular (Oruc et al ., 2004 ; Desai et al ., 1984 ), anticonvulsant (Shrivastava et al ., 1999 ; Kumar et al ., 2003 ; Gupta et al ., 2008 ; Stillings et al ., 1986 ; Jatav et al ., 2008 ), CNS depressant (Jatav et al ., 2008 ), hypoglycaemic (Hanna et al ., 1995 ; Pattan et al ., 2009 ), anti-inflammatory (Sharma et al ., 2008 ; Varandas et al ., 2005 ) and anticancer (Noolvi et al ., 2011 ; Kumar et al ., 2010 ) properties. At the same time, the 1,3,4-thiadiazole fragment appears in a number of clinically used drugs such as acetazolamide; methazolamide; butazolamide (diuretic); sulfamethiazole (antibacterial); cefazolin, cefazedone (antibiotic); atibeprone (anti-depressant); glybuthiazole, glybuzole (antidiabetic); and tebuthiuron (insecticide) (Wilson and Gisvold, 1991 ; Abrahum, 2003 ; Supran et al ., 2003 ).…”